Now that Pfizer Inc. and Moderna, Inc. have launched Phase III programs for their COVID-19 vaccine candidates, industry and policy makers can start to envision what a world with an inoculation might look like, even as plenty of questions remain.
A US House hearing held a week before the trail announcements offered hints as to what the lawmakers will be...







